Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Management
Changes among Senior Management Personnel of the Company25-03-2024
25-03-2024
Buy Gland Pharma; target of Rs 2240: Motilal Oswal
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 2240 in its research report dated March 20, 2024.21-03-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meeting on 21.03.202419-03-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation regarding Investor Meets Scheduled on 19.03.2024 and 20.03.202414-03-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation regarding Investor Meet scheduled on 13.03.2024 and 14.03.202411-03-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Meet intimation07-03-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation regarding the Analyst/ Institutional Investor Meetings scheduled on 07.03.2024 and 08.03.202404-03-2024
Gland Pharma Ltd - 543245 - Appointment Of President For Phixen S.A.S. (Cenexi); The Wholly-Owned Step-Down Subsidiary Of Gland Pharma Limited
Appointment of President for Phixen S.A.S. (Cenexi); the wholly owned step down subsidiary of Gland pharma Limited27-02-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings Call Transcript for the call held on 14.02.202421-02-2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst/Investor Meet scheduled on 21.02.202419-02-2024